Revelation Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REVB and other ETFs, options, and stocks.About REVB
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity.
REVB Key Statistics
Stock Snapshot
The current Revelation Biosciences(REVB) stock price is $1.28, with a market capitalization of 4.61M. The stock trades at a price-to-earnings (P/E) ratio of -0.02.
On 2026-03-06, Revelation Biosciences(REVB) stock traded between a low of $1.21 and a high of $1.29. Shares are currently priced at $1.28, which is +5.4% above the low and -1.1% below the high.
The Revelation Biosciences(REVB)'s current trading volume is 36.44K, compared to an average daily volume of 96.85K.
During the past year, Revelation Biosciences(REVB) stock moved between $1.19 at its lowest and $45.60 at its peak.
During the past year, Revelation Biosciences(REVB) stock moved between $1.19 at its lowest and $45.60 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.